BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20621714)

  • 1. The creation of the Comparative Oncology Trials Consortium Pharmacodynamic Core: Infrastructure for a virtual laboratory.
    Paoloni M; Lana S; Thamm D; Mazcko C; Withrow S
    Vet J; 2010 Jul; 185(1):88-9. PubMed ID: 20621714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and comparative imaging.
    LeBlanc AK
    ILAR J; 2014; 55(1):164-8. PubMed ID: 24936036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer researchers usher in dog days of medicine.
    Mack GS
    Nat Med; 2005 Oct; 11(10):1018. PubMed ID: 16211022
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of clinical trials in veterinary oncology.
    Burton J; Khanna C
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials.
    Calvert AH; Plummer R
    Clin Cancer Res; 2008 Jun; 14(12):3664-9. PubMed ID: 18559580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials going to the dogs: canine program to study tumor treatment, biology.
    Mack GS
    J Natl Cancer Inst; 2006 Feb; 98(3):161-2. PubMed ID: 16449674
    [No Abstract]   [Full Text] [Related]  

  • 9. Fighting cancer in dogs. Morris Animal Foundation leads campaign to find cures.
    Rezendes A
    J Am Vet Med Assoc; 2007 May; 230(9):1287-8. PubMed ID: 17489135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy discussion].
    van den Heuvel W; van der Wijden M; Spiekermann S
    Tijdschr Diergeneeskd; 2004 Jun; 129(11):382. PubMed ID: 15211910
    [No Abstract]   [Full Text] [Related]  

  • 11. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
    Gordon I; Paoloni M; Mazcko C; Khanna C
    PLoS Med; 2009 Oct; 6(10):e1000161. PubMed ID: 19823573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
    Kinders R; Parchment RE; Ji J; Kummar S; Murgo AJ; Gutierrez M; Collins J; Rubinstein L; Pickeral O; Steinberg SM; Yang S; Hollingshead M; Chen A; Helman L; Wiltrout R; Simpson M; Tomaszewski JE; Doroshow JH
    Mol Interv; 2007 Dec; 7(6):325-34. PubMed ID: 18199854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in tumour responses to cancer chemotherapy.
    Lawrence J; Cameron D; Argyle D
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of tumors in dogs].
    Austie BA; Rutteman GR; Misdorp W
    Tijdschr Diergeneeskd; 1988 Mar; 113(6):299-310. PubMed ID: 3283998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
    Paoloni MC; Tandle A; Mazcko C; Hanna E; Kachala S; Leblanc A; Newman S; Vail D; Henry C; Thamm D; Sorenmo K; Hajitou A; Pasqualini R; Arap W; Khanna C; Libutti SK
    PLoS One; 2009; 4(3):e4972. PubMed ID: 19330034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer clinical trials: development and implementation.
    Vail DM
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1033-57; v. PubMed ID: 17950881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perils and pitfalls of clinical trials--experience from human oncology.
    Pitson G; Fyles A
    J Vet Intern Med; 2000; 14(4):392-4. PubMed ID: 10935888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.